K201505: Simplexa Flu A/B & RSV Direct Gen II, Simplexa Flu A/B & RSV Positive Control Pack (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K201505 (Simplexa Flu A/B & RSV Direct Gen II, Simplexa Flu A/B & RSV Positive Control Pack, cleared 2020-08-22 for Diasorin Molecular, LLC) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K201505
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK201505
Cleared Device Trade / Generic NameSimplexa Flu A/B & RSV Direct Gen II, Simplexa Flu A/B & RSV Positive Control Pack
FDA Applicant on FilingDiasorin Molecular, LLC
FDA 3-Letter Product ClassificationProduct Code OCC
FDA Substantial Equivalence Decision Date2020-08-22
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Inspect consolidated manufacturer lineage at Diasorin Molecular, LLC, compare peer devices under FDA Product Code OCC, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.